Both in Biotechnology
Cel-Sci vs Quince Therapeutics
Over the past year CVM returned −79.7% and QNCX returned −90.3%; their daily moves had a correlation of 0.03.
CVM −79.7% QNCX −90.3%Growth of $1, one year, split-adjusted
| Metric | CVM | QNCX |
|---|---|---|
| Price | $1.79 | $31.17 |
| Market cap | $31.5M | $31.7M |
| Today | +5.29% | +7.48% |
| 1 month | +14.7% | −7.6% |
| 6 months | −41.7% | +53.9% |
| Year to date | −66.0% | −95.3% |
| 1 year | −80.0% | −90.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $255.6K | $116.0M |
| Dividend yield | — | — |
| Volatility (60d) | 81.5% | 71.9% |
| Short % of float | 7.6% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).